Redgate welcomes Microsoft as the Premier Sponsor of PASS Data Community Summit 2022
Redgate Software announced today that Microsoft will be the Premier Sponsor of the 2022 PASS…
News
Sofwave™ to Showcase SUPERB™ (Synchronous Ultrasound Parallel Beam Technology) Live and In-Person at 5CC International Aesthetic Medical and Dermatology Conference
Sofwave to host showcase booth from September 1-4 Facial and neck treatment workshop held on…
Oyster Point Pharma to Present Analyses at the Women in Ophthalmology Summer Symposium
PRINCETON, N.J., Aug. 25, 2022 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a…
Longeveron Receives Intent to Grant Notice from the European Patent Office for Methods to Monitor Efficacy of Lomecel-B™ Cell Therapy Through Levels of Vascular Biomarker
Issued claims will protect use of a biomarker to assess response to Lomecel-B™ in patients…
Catalyst Biosciences, Inc. Declares Special Cash Dividend of $1.43 per share
SOUTH SAN FRANCISCO, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO)…
Anthos Therapeutics Launches Second Phase 3 Clinical Trial of Its Dual-acting Factor XI Inhibitor, Abelacimab
Abelacimab is the only Factor XI inhibitor currently being evaluated in Phase 3 trials The…
Frontier Medicines Announces the Appointment of Seasoned Legal Executive Mark Dizon, J.D., as General Counsel
SOUTH SAN FRANCISCO, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) — Frontier Medicines Corporation, a precision…
TG Therapeutics Announces Results from the ULTIMATE I & II Phase 3 Trials of Investigational Ublituximab in RMS Published in The New England Journal of Medicine
Ublituximab is an investigational targeted B-cell therapy that shows superior efficacy when compared with teriflunomide,…
OpGen Launches Ares Sequencing Services in the U.S. from its Rockville, Maryland Laboratory
Expanding services and offerings to the infectious disease community throughout the U.S. provides revenue growth…
Century Therapeutics Receives Study May Proceed Notification from FDA for CNTY-101, the First Allogeneic Cell Therapy Product Candidate Engineered to Overcome Three Major Pathways of Host vs Graft Rejection
– Investigational New Drug Application for CNTY-101, a CAR-iNK product candidate targeting CD19 for B-cell malignancies,…
Todos Medical Enrolls Female Long COVID Patient Unable to Secure Testing While Symptomatic for MonkeyPox into Provista Diagnostics Case Study Series
Patient denied testing for weeks due to risk of physician infection & non-MSM status Amerimmune…
Iovance Biotherapeutics Initiates Biologics License Application (BLA) Submission for Lifileucel in Advanced Melanoma
First TIL Therapy BLA Submission Initiated with U.S. Food and Drug Administration Complete BLA Submission…
Clearside Biomedical to Present at the Ophthalmology Futures Retina Forum 2022
ALPHARETTA, Ga., Aug. 25, 2022 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing…
U.S. Government Exercises Option to Purchase Additional RAPIVAB® (peramivir injection) from BioCryst for Pandemic Influenza Preparedness
RESEARCH TRIANGLE PARK, N.C., Aug. 25, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
Aclaris Therapeutics Announces Patent License Agreement with Lilly for Alopecia Areata
WAYNE, Pa., Aug. 25, 2022 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage…
ibex Honduras Continues to Grow; Hiring 500 New Agents
Award-Winning BPO Offers Unmatched Employee Experience, Benefits, and Career Opportunities ibex Honduras Continues to Grow;…
Exterro Launches FTK® Suite 7.6, Introducing Mobile Parsing, Automation Capabilities, and Industry-First Remote Endpoint Triage
Exterro FTK Gets Evidence Into the Hands of Investigators Faster Than Ever PORTLAND, Ore., Aug….
Kiteworks-enabled Private Content Networks Simplify and Deliver Rapid CMMC 2.0 Compliance
Over 300,000 DoD contractors and subcontractors can address almost 90% of CMMC 2.0 Level 2…
SimpleNexus to Power User-Friendly Mobile Homebuying Experience for Approved Mortgage
Locally owned Indiana lender will leverage SimpleNexus’ homeownership platform as a competitive advantage with tech-savvy…
VitalHub Corp. Announces Intention to Make a Normal Course Issuer Bid
Toronto, Ontario–(Newsfile Corp. – August 25, 2022) – VITALHUB CORP. (TSX: VHI) (the “Company” or…